3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
4
Plasma cell
4
Breast
3
Genitourinary
2
Other hematologic neoplasm
1
Head & Neck
1
Gastrointestinal
1
CNS
1
Conditions
Head and Neck Neoplasms
1284
Squamous Cell Carcinoma of Head and Neck
707
Thyroid Neoplasms
297
Carcinoma, Non-Small-Cell Lung
180
Mouth Neoplasms
177
Neoplasms
173
Breast Neoplasms
172
Lung Neoplasms
152
Salivary Gland Neoplasms
143
Oropharyngeal Neoplasms
132
Nasopharyngeal Carcinoma
128
Melanoma
117
Carcinoma, Squamous Cell
116
Colorectal Neoplasms
112
Laryngeal Neoplasms
108
Ovarian Neoplasms
102
Esophageal Neoplasms
100
Nasopharyngeal Neoplasms
96
Prostatic Neoplasms
92
Pancreatic Neoplasms
92
Stomach Neoplasms
88
Uterine Cervical Neoplasms
86
Neoplasm Metastasis
86
Thyroid Cancer, Papillary
78
Carcinoma, Renal Cell
78
Urinary Bladder Neoplasms
74
Thyroid Nodule
68
Sarcoma
65
Colonic Neoplasms
63
Small Cell Lung Carcinoma
62
Interventions
etelcalcetide hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Bone Diseases
×
Head & Neck
×
Clear all
NCT03960437
2023-09-21
Parsabiv-MBD
Columbia University
Phase 2
Completed
22 enrolled
14 charts